首页> 外文会议>European Haematology Association >Ex-Vivo Expansion of Both Committed and Pluripotent Hematopoietic Progenitor Cells
【24h】

Ex-Vivo Expansion of Both Committed and Pluripotent Hematopoietic Progenitor Cells

机译:犯罪和多能造血祖细胞的前体内扩展

获取原文

摘要

UCB ex-vivo expansion has been proposed as a method to increase the number of cells available for transplantation. We investigated total NCs, CD34+ and CD34+CD38- pluripotent non committed cell fold increase after ex-vivo expansion of CD34+ purified cells in the presence of different human growth factors combinations. Results show that the addition or the withdrawal of IL-3 to the early-acting cytokines flt3-L and TPO, is crucial to influence the total NC fold increase and the ratio of immature versus committed cells. We therefore propose the ezpan-sion of each UCB sample in two aliquots containing different cytokines; this protocol allows high NC proliferation as well as high number of non committed pluripotent cells in the final product.
机译:已经提出了UCB前体内扩展作为增加可用于移植的细胞数量的方法。在不同人体生长因子组合的存在中,我们研究了CD34 +纯细胞的前体内扩增后的NCS,CD34 +和CD34 + CD38-多能非致电细胞折叠。结果表明,IL-3向早期作用细胞因子FLT3-L和TPO的添加至关重要,对影响总NC折叠增加和未成熟的细胞的比例至关重要。因此,我们在含有不同细胞因子的两种等分试样中提出了每个UCB样品的EZPAN-SION;该协议允许在最终产品中具有高NC增殖以及大量非犯相关的多能细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号